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ABSTRACT 33 
Importance: Chronic Tic Disorders (CTD), including Tourette Syndrome (TS), are assumed to 34 
be strongly familial and heritable. While gene-searching efforts are well underway, precise 35 
estimates of familial risk and heritability are lacking. Previous controlled family studies were 36 
small and typically conducted within specialist clinics, resulting in potential ascertainment biases. 37 
They were also underpowered to disentangle genetic from environmental factors contributing to 38 
the observed familiality. Twin studies have been either very small or based on parent-reported 39 
tics in population-based (non-clinical) twin samples. 40 
Objective: To provide unbiased estimates of familial risk and heritability of TS/CTD at the 41 
population level. 42 
Design and Setting: Population cohort, multigenerational, family study. 43 
Participants: Using a validated algorithm, we identified 4,826 individuals diagnosed with 44 
TS/CTD (76% male) in the Swedish National Patient Register between 1969-2009. 45 
Main outcome measure: Risks (Odds Ratios; OR) for TS/CTD in all biological relatives of 46 
probands, compared to relatives of unaffected individuals (matched on a 1:10 ratio) from the 47 
general population. Structural equation modeling was used to estimate the heritability of 48 
TS/CTD. 49 
Results: The risk for TS/CTD amongst relatives of TS/CTD probands increased proportionally 50 
to the degree of genetic relatedness. The risks for first-degree relatives (OR= 18.69, 95% CI 51 
14.53-24.05) were significantly higher than for second-degree relatives (OR= 4.58, 95% CI 52 
3.22-6.52) and third-degree relatives (OR= 3.07, 95% CI 2.08-4.51). First-degree relatives at 53 
similar genetic distances (e.g. parents, siblings, offspring) had similar risks for TS/CTD, despite 54 
different degrees of shared environment. The risks for full siblings (50% genetic similarity; OR= 55 
17.68, 95% CI 12.90-24.23) were significantly higher than that for maternal-half siblings (25% 56 
genetic similarity; OR= 4.41, 95% CI 2.24-8.67), despite similar environmental exposures. The 57 
 3
heritability of TS/CTD was estimated to be 0.77 (95% CI 0.70-0.85). There were no differences 58 
in familial risk or heritability between male and female patients. 59 
 60 
Conclusions and relevance: TS/CTD clusters in families primarily due to genetic factors and 61 
appears to be amongst the most heritable neuropsychiatric conditions. 62 
 63 
Keywords: Tourette syndrome, Chronic Tic Disorders, family study, genetic epidemiology 64 
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INTRODUCTION 65 
Tourette Syndrome (TS) is thought to be a strongly familial and heritable neuropsychiatric 66 
disorder 1. Controlled family studies have reported a 10- to 100-fold increase in the rates of TS 67 
in first-degree relatives of affected individuals, compared to control relatives 2-6. Furthermore, 68 
chronic tic disorders (CTD) also occur more frequently among first-degree relatives of TS 69 
probands, compared to relatives of controls (7- to 22-fold increase), suggesting that TS and CTD 70 
share common etiological factors 1. These previous family studies were carefully conducted but 71 
also had important limitations. First, the estimates of family risk have varied broadly, suggesting 72 
that previous studies may have been underpowered to provide precise estimates of familial 73 
transmission. Second, families were primarily recruited from specialist clinics, potentially 74 
resulting in the inclusion of more severe and impaired cases. Families with several affected 75 
members may have been more likely to volunteer for participation, thus inflating the familial 76 
risk. These possible biases can optimally be addressed by examining the familial structure of 77 
TS/CTD at the population level 7, recruiting patients from non-specialist clinics and randomly 78 
selecting control families from the general population. Third, studies conducted to date were 79 
underpowered to calculate risks for relatives with different degrees of genetic relatedness to the 80 
proband and different degrees of shared environmental exposures. Consequently, these studies 81 
could not disentangle genetic from environmental factors contributing to the observed familiality 82 
of TS/CTD. Fourth, previous family studies were too small to examine possible gender 83 
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differences in familiality and heritability; this is of critical importance given that TS/CTD is 84 
much more common in males than in females 8-12.  85 
Twin studies are ideal to disentangle these aetiological factors, based on the different 86 
genetic resemblance of twins. To our knowledge, only two small twin studies of diagnosed 87 
TS/CTD cases have been published to date. Price and colleagues 13 recruited 30 identical 88 
(monozygotic (MZ)) and 13 same-sex non-identical (dizygotic (DZ)) twin pairs (mean age 18 89 
years) from the Tourette Syndrome Association and found that 77% of MZ twins and 23% of 90 
DZ twins were concordant for tic disorders (TS or CTD). The MZ concordance rate reached 91 
100% for TS or CTD when direct observational interviews were conducted on the same twin 92 
sample 14. In another study of 16 pairs of MZ twins (mean age 13 years), 56% were concordant 93 
for TS and 94% were concordant for tic disorders but, because DZ twins were not included, no 94 
conclusions could be made about heritability 15. Though the higher MZ concordance rates have 95 
been interpreted as implicating genetic factors as strongly contributing to the aetiology and 96 
familial transmission of TS/CTD, and gene-searching efforts are well underway 16-18, this 97 
evidence comes from small samples that may not represent broader TS and chronic tic 98 
populations. 99 
Three recent population-based studies have examined the heritability of parent-rated 100 
tics in children, resulting in modest heritability estimates. A Japanese study of 1896 twin pairs 101 
aged 3-15 (mean 11 years) reported modest heritability estimates (around 30%) for parent-rated 102 
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tics 19. A British study including 854 pairs of 6-year old twins found evidence for strong familial 103 
effects on parent-rated tics (61%) but was unable to separate genetic from shared environmental 104 
sources of familial aggregation due to power issues 20. A large nationally-representative sample 105 
of over 10,000 Swedish twins aged 9-12, reported heritability estimates for parent-rated tics of 106 
56% [95% confidence intervals (CIs) 37-68], with the remaining variance due to non-shared 107 
environmental factors 21. Although the assessment instrument varied across these studies, 108 
collectively, they suggest moderate heritability of parent-rated tics in young people, but it is 109 
unclear to what extent these findings can be extrapolated to clinically diagnosed tic disorders.  110 
In an attempt to overcome some of these limitations and provide unbiased estimates of 111 
family clustering and heritability of TS/CTD at the population level, we linked and analyzed 112 
data from two Swedish population-based registers and tested three hypotheses: 1) TS/CTD will 113 
cluster in families at the population level; 2) the risk of TS/CTD will increase proportionally to 114 
the degree of genetic relatedness to the proband; 3) shared environment effects will be negligible. 115 
In exploratory analyses, we also examined possible gender differences in the patterns of familial 116 
clustering of TS/CTD. 117 
 118 
 119 
 120 
 121 
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METHODS 122 
Swedish registers  123 
Following approval from the Regional Ethics Committee in Stockholm, we linked two Swedish 124 
national registers, using the individual national registration numbers assigned at birth. 125 
The Multi-Generation Register contains information about the identity of biological 126 
and adoptive parents of each individual born in Sweden since 1932 (with the mother as 127 
informant) or who immigrated to Sweden together with one or both parents before the age of 18 128 
years and lived in Sweden at any time since 1961. Unless the biological/adoptive parents have 129 
actually lived in Sweden since 1947, when the national personal identification number was 130 
introduced, it is not possible to identify them. The father was defined either as the mother’s 131 
husband at the time of birth, or the man acknowledged as father by unmarried mothers. With 132 
information on parents, it is possible to create family pedigrees for all individuals with relatives 133 
at increasing genetic and environmental distances from each index person.  134 
The National Patient Register contains diagnostic information about patients treated in 135 
Sweden since 1969, with each consultation as a unique record in the register. Initially, it 136 
contained information on all inpatient care. From 2001, however, it also includes individuals 137 
with outpatient visits to specialist physicians (other than general practitioners) that resulted in 138 
one or more diagnoses according to the ICD-10 22.  139 
 140 
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ICD diagnostic codes 141 
The ICD codes for TS/CTD have been validated in Sweden (Rück et al, submitted). Briefly, we 142 
obtained a random sample of TS/CTD patient records from 3 Swedish counties (N=73), of 143 
which 64 contained sufficient information for analysis. Each file was carefully reviewed and 144 
blindly rated by two independent physicians. There was 100% of agreement between the two 145 
raters regarding the presence or absence of a chronic tic disorder (Kappa = 1, p<0.001). Overall, 146 
the ICD codes had excellent validity, with a positive predictive value (PPV) of 92% for both 147 
raters. The PPVs for ICD-8, ICD-9 and ICD-10 cases were 0.89, 0.86 and 0.97, respectively.  148 
 Further examination of specific ICD-10 sub-codes, revealed that the majority of 149 
patients who had F95.1 (CTD) codes in the register were diagnosed as TS (F95.2) by the raters 150 
(both motor and vocal tics were identified in the clinical histories). Unspecified tic disorder 151 
(F95.9) cases were diagnosed by the raters as either TS (F95.2), CTD (F95.1), unspecified tic 152 
disorder (F95.9) or transient tics (F95.0), suggesting that F95.9 is used more freely by clinicians. 153 
Consequently, we developed an algorithm to ensure that individuals who had transient tics as 154 
their only or final diagnostic code within the same year of the initial diagnosis were excluded 155 
from the analyses. Furthermore, individuals who received an initial diagnosis of transient, ‘other’ 156 
or unspecified tics were only included if they received at least an additional diagnosis of a tic 157 
disorder, except if the last available diagnosis was of transient tic disorder given within the same 158 
year of the initial diagnosis (Rück et al, submitted). We did not exclude any participants based 159 
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on comorbidities, as we preferred not to make assumptions about the hierarchical structure of 160 
mental disorders. 161 
 162 
Data Analyses 163 
The risk of TS/CTD in relatives of probands with TS/CTD were compared with the risk in 164 
relatives of 10 randomly selected, unaffected control individuals matched by sex, birth year and 165 
county of residence at the time of the first recorded TS/CTD diagnosis of the proband. Relatives 166 
were also matched by sex and birth year. For instance, for each proband, we detected all possible 167 
proband-full sibling pairs, and randomly selected 10 control-full sibling pairs matched to 168 
probands-sibling pairs by sex and birth year. Because each proband may appear multiple times 169 
in different categories (e.g. parent, sibling and cousin) depending on family structure, the 170 
matching was done separately for each proband-relative pair to ensure adequate control of 171 
cohort/period effects and allow for equal time at risk for proband-relatives and control-relatives. 172 
The matching procedure was used for all available first-, second- and third degree relatives of 173 
each proband. We also examined potential gender effects by separately analyzing respective 174 
pairs of male-male, male-female, female-female and female-male probands and relatives.  175 
Because the data were matched and the outcome dichotomous, we employed a 176 
conditional logistic regression model with the PROC PHREG procedure in SAS, version 9.3 23. 177 
Because several possibly correlated pairs of relatives from every family could be included in the 178 
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analysis, we adjusted for the non-independence of family members (e.g. several sibling pairs, 179 
which share the same parents) by computing corrected (less narrow) confidence intervals with a 180 
robust sandwich estimator (covsandwich option in PHREG). 181 
By assuming that a continuous normally distributed liability underlies the observed 182 
dichotomous diagnosis of TS/CTD, the tetrachoric correlations of TS/CTD between family 183 
members can be estimated. These are often employed in twin and family studies to obtain 184 
approximate heritability estimates using structural equation modeling. We fitted 185 
liability-threshold models using full siblings and maternal half-siblings to decompose the 186 
variance in liability of TS/CTD into additive genetic effects (A), shared environmental effects 187 
(C), and non-shared environmental effects (E). Age and sex were adjusted for in the threshold of 188 
TS/CTD. The genetic correlation was fixed to 0.5 for full siblings (they share on average 50% of 189 
their segregating genes), and to 0.25 for maternal half-siblings (sharing 25% of their genes), and 190 
we assumed that the family environment is shared between full siblings and maternal 191 
half-siblings (Supplementary Materials). We began our model fitting with a full ACE model 192 
allowing sex difference for the estimates of ACE. We then sought to simplify the model by 193 
equating the ACE estimates between males and females, and then dropped the shared 194 
environmental effects. Goodness of fit between the different models was assessed by a 195 
likelihood-ratio test. Maximum likelihood estimation and univariate model fitting were 196 
performed using the structural equation modeling package OpenMx in R.  197 
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 198 
RESULTS 199 
Sample characteristics 200 
Our algorithm resulted in the identification of 4,826 individuals diagnosed with TS/CTD (3,678 201 
or 76.2% male; age mode = 10) between 1969-2009. Of the TS/CTD subjects, 73% had at least 202 
one lifetime psychiatric comorbidity (Attention Deficit Hyperactivity Disorder 38%, 203 
Obsessive-Compulsive Disorder 15%, Pervasive Developmental Disorders [PDD] 20%, Mental 204 
Retardation [MR] 21%, Depression 16%, Anxiety disorders 12%, Other neurotic, stress-related 205 
and somatoform disorders 14%, Substance use 10%). 206 
 207 
Familial risk of TS/CTD 208 
First-degree relatives of individuals with TS/CTD had significantly higher risk of having 209 
TS/CTD than second-relatives and third-degree relatives. In turn, the odds ratios (ORs) for 210 
second-degree relatives were higher than for third-degree relatives, though the confidence 211 
intervals overlapped (Table 1 and Figure 1). The pattern of results did not change substantially 212 
when cases with PDD or MR were excluded from the analyses (Supplemental Figure 1). 213 
Shared environmental influences on TS/CTD appeared to be considerably less 214 
important. Full siblings, parents, and children of TS/CTD probands (all with 50% genetic 215 
similarity but siblings assumed to have more shared environment as they grew up together in the 216 
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same family approximately during the same period of time) had comparable risks. Additionally, 217 
the risks for full siblings (50% genetic similarity) were significantly higher than that for 218 
maternal-half siblings (25% genetic similarity), despite similar shared environmental exposures. 219 
Furthermore, the risks did not differ significantly between maternal and paternal half-siblings 220 
(both with 25% genetic similarity but with maternal half-siblings sharing more environment as 221 
the vast majority (90%) of children in Sweden continue to live with their mother after parental 222 
divorce or separation; Supplementary Materials) 25. Finally, first cousins (12.5% genetic 223 
similarity) had a 3-fold higher risk of having TS/CTD compared to controls, despite no or 224 
marginal shared environmental exposures with the TS/CTD proband. 225 
 226 
Gender effects 227 
Analyses by gender of the proband and gender of the relative revealed a higher number of 228 
male-male dyads, but the risks and tetrachoric correlations (which are not affected by sample 229 
size) were approximately similar for male-male, male-female, female-male and female-female 230 
dyads (Table 2).  231 
 232 
Heritability estimates 233 
Tetrachoric correlations were approximately double for full siblings than for maternal 234 
half-siblings (Table 1). There was no evidence of quantitative sex differences in the liability to 235 
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TS/CTD. In the full ACE model, the variance in liability of TS/CTD was largely attributable to 236 
additive genetic factors (0.72, 95% CI 0.42-1.00]), with negligible effect of shared environment 237 
(0.03, 95% CI 0.00-0.16]. The remaining variance was attributable to non-shared environmental 238 
influences and measurement error (0.25, 95% CI 0.08-0.43]. The best fitting model included 239 
additive genetic factors (0.77, 95% CI 0.70-0.85) and non-shared environmental factors (0.23, 240 
0.15-0.30). The shared environment component could be dropped without any significant loss of 241 
fit (Table 3). 242 
 243 
DISCUSSION 244 
Extending previous, much smaller, family studies primarily conducted in specialist clinical 245 
settings, TS/CTD was significantly more prevalent among biological relatives of TS/CTD 246 
probands than in relatives of matched population controls. Further, the risk of TS/CTD in 247 
relatives increased significantly with increasing genetic relatedness to the proband. The pattern 248 
of results was similar in male and female patients. The heritability of TS/CTD was estimated to 249 
be approximately 77%, with the remaining variance being attributable to non-shared 250 
environmental influences and measurement error.  251 
Together with the previous family and twin literature, largely derived from clinical 252 
samples of European origin, our data confirm that TS/CTD runs in families primarily due to 253 
genetic factors. Previous twin studies of strictly diagnosed TS/CTD 13,15 were too small to 254 
provide robust heritability estimates, whereas population-based (non-clinical) studies of 255 
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parent-rated tics 19-21 estimated the genetic contribution to range between 30-60% but were 256 
limited by the lack of clinician-based diagnostic assessments. Recent efforts to estimate the 257 
heritability of TS from genotyped data employing genome-wide complex trait analysis methods 258 
have also estimated the heritability of TS to be around 60%17. Our estimates suggest that 259 
TS/CTD may be even more heritable than previously thought. 260 
Although we cannot conclusively rule out shared environmental factors, these appear 261 
to make a much smaller contribution to the etiology of the disorder. Instead, unique or 262 
non-shared environmental influences may confer increased risk to developing TS/CTD. A range 263 
of environmental risk factors for TS/CTD has been tentatively identified, including older 264 
paternal age and a number of peri-natal adversities (e.g., severe maternal stress, severe nausea 265 
and vomiting, smoking during the pregnancy as well as low birth weight and delivery 266 
complications low Apgar scores at birth) 26-28. However, longitudinal, genetically informed 267 
studies are still rare; such studies should be prioritized alongside gene-searching efforts. The 268 
identification of genetic differences in susceptibility to particular environments (gene by 269 
environment interactions) in TS/CTD will be an important challenge for the future. Finally, the 270 
possibility of gene-environment correlations should also be investigated, as it is plausible that 271 
genetic factors could influence the specific environmental experiences of children vulnerable to 272 
developing TS/CTD 29. 273 
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While chronic tic disorders are clearly more prevalent in males, both in clinical and 274 
epidemiological samples 8-10,12,30, our results suggest that the familial risk for TS/CTD is 275 
comparable in male and female probands, regardless of the sex of the relative. The implication 276 
for molecular genetic research would be that when specific genes associated with TS/CTD are 277 
identified, they will be associated with TS/CTD in both sexes and that they will have similar 278 
effect sizes in males and females. However, these findings do not preclude the role of 279 
gender-specific factors during embryonic and fetal development in the causation of the disorder 280 
31,32. Female sex may be a protective factor against TS/CTD; whether females require a greater 281 
familial etiologic load to manifest the phenotype, as has been suggested in Autism Spectrum 282 
Disorder 33, is an interesting question for the future.  283 
 284 
Strengths and limitations 285 
Strengths of the present study include the large population-based sample of TS/CTD cases 286 
diagnosed in Sweden over 40 years, all their relatives, as well as carefully matched, randomly 287 
selected controls. This ensured minimal risk of selection, recall, and report biases for both 288 
TS/CTD and control families. Further, this is the first study to have sufficient power to examine 289 
the familial risk of TS/CTD across relatives at varying genetic and environmental distances from 290 
the probands. Another important strength was careful selection of probands based on our 291 
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validation of the ICD codes in the Swedish National Patient Register, which resulted in an 292 
algorithm designed to minimize the risk of false positive diagnoses.  293 
Registers also have limitations. Individuals diagnosed with TS/CTD in the National 294 
Patient Register probably represent only a fraction of all cases in the Swedish population. Many 295 
individuals with mild tics may not seek help and, thus, may never be diagnosed or treated. 296 
Furthermore, the National Patient Register only includes patients seen by specialist physicians 297 
(e.g. pediatricians, neurologists or psychiatrists); those diagnosed in primary care by general 298 
practitioners or other professionals (e.g. nurses) are not included. Finally, outpatients were only 299 
included in the register from 2001. Thus, the register may only include the more severe and 300 
complex forms of TS/CTD (in our cohort, over 70% of patients had at least one lifetime 301 
psychiatric comorbidity) and our results may not generalize to milder forms of the disorder. 302 
However, the incomplete coverage of TS/CTD cases in the Register should be constant across 303 
the families of probands and the families of comparison subjects, thus not influencing our 304 
estimates. It is theoretically possible that having a relative with TS/CTD increases the chance of 305 
seeking help/receiving a diagnosis, though our findings suggest small or negligible shared 306 
environmental effects, which would argue against this possibility. Another limitation is that 307 
longitudinal registers are subject to ‘left truncation’ or missing data before the date the register 308 
started, which may result in greater prevalence of TS/CTD in younger generations. However, 309 
since we matched for birth year and time at risk, such losses would be similar for both case and 310 
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control dyads and not affect family risks. Despite the very large sample size, our study could not 311 
distinguish between TS and CTD because our validation study suggested that clinicians in 312 
Sweden often use these diagnostic codes indistinctly. Finally, our results may not generalize to 313 
non-European populations; it has been suggested that ethnic differences in allelic frequencies 314 
may explain the low prevalence of TS/CTD in non-European populations 10.  315 
 316 
Conclusions 317 
With these caveats in mind, our results indicate that TS/CTD is a strongly familial disorder 318 
within the Swedish population and the observed pattern of familiality is consistent with a likely 319 
genetic etiology. Our heritability estimates place TS/CTD amongst the most heritable 320 
neuropsychiatric conditions.  321 
 322 
 323 
 324 
 325 
 326 
 327 
 328 
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Table 1. Risks of TS/CTD in relatives of probands diagnosed with TS/CTD in Sweden (1969-2009) compared with relatives of matched controls, and 436 
tetrachoric correlations. 437 
 438 
 439 
 440 
 441 
Relation to proband 
Average degree of 
genetic similarity 
Number of dyads 
Concordant pairs 
(expected) 
Concordant pairs 
(observed) 
Matched odds ratio 
(95% CI) 
Tetrachoric 
correlation 
(Standard Error) 
First-degree relatives            
   Full siblings  50% 59,518 16.4 112 17.68 (12.90-24.23) 0.40 (0.01) 
   Parents 50% 95,675 3.2 24 21.08 (11.19-39.68) 0.30 (0.02) 
   Offspring 50% 16,572 3.1 24 24.74 (12.42-49.30) 0.30 (0.02) 
   Total 50% 171,765 22.8 160 18.69 (14.53-24.05)  
Second-degree relatives    
  Maternal half-siblings 25% 15,767 5.2 16 4.41 (2.24-8.67) 0.22 (0.03) 
  Paternal half-siblings 25% 18,372 3.0 8 3.19 (1.27-8.00) 0.13 (0.04) 
  Uncles or aunts 25% 126,251 3.3 13 5.49 (3.04-9.89) 0.15 (0.03) 
  Nephews or nieces 25% 30,638 3.4 13 5.24 (2.83-9.72) 0.15 (0.03) 
  Total 25% 349,310 15.9 57 4.58 (3.22-6.52) 
Third-degree relatives    
  First cousins  12.5% 238,822 21.8 56 3.07 (2.08-4.51) 0.11 (0.01) 
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Table 2. Gender effects: Risks (OR, 95% Confidence Intervals and Tetrachoric correlations) for the presence of TS/CTD in relatives of probands 442 
diagnosed with TS/CTD. 443 
 444 
 445 
OR, Odds Ratios; CI, Confidence Interval; TC, Tetrachoric correlation; SE, Standard Error. 446 
 447 
 448 
 449 
  Male-male pairs Male-female pairs Female-female pairs Female-male pairs 
Relation to 
proband 
Concorda
nt pairs, 
observed 
Matched 
OR (95% 
CI) 
TC (SE) Concorda
nt pairs, 
observed 
Matched 
OR (95% 
CI) 
TC (SE) Concorda
nt pairs, 
observed 
Matched 
OR (95% 
CI) 
TC (SE) Concorda
nt pairs, 
observed 
Matched 
OR (95% 
CI) 
TC (SE) 
First-degree 
relatives, total 
84 
16.75 
(11.95-23.5
0) 
0.34 (0.01 ) 
31 
23.42 
(13.26-41.3
8) 
0.32 (0.02 ) 
14 
17.48 
(7.45-41.02
) 
0.33 (0.03 ) 
31 
21.65 
(12.36-37.9
2) 
0.32 (0.02 ) 
Second-degree 
relatives, total 
35 
4.78 
(3.00-7.64) 
0.12 (0.02 ) 
9 
4.51 
(2.29-8.90) 
0.09 (0.03 ) 
4 
5.53 
(1.58-19.37
) 
0.12 (0.04 ) 
9 
3.86 
(1.97-7.57) 
0.09 (0.03 )  
Third-degree 
relatives 
32 
2.69 
(1.71-4.24) 
0.11 (0.02 ) 
12 
4.88 
(2.60-9.18) 
0.13 (0.03 ) 
0 - 
- 
12 
4.29 
(2.31-7.96) 
0.13 (0.03 ) 
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Table 3. Model fitting results based on the family data.  450 
 451 
a Best fitting model. 452 
Notes: - 2LL = minus twice the log likelihood; χ2 = differences in -2LL statistic between submodel and full model; Δ df = change in degrees of freedom 453 
between submodel and full model; p=probability; AIC = Akaike Information Criterion. 454 
Models -2 LL χ2 Δ df p-value AIC Compared to 
I. ACE model with sex difference 142638.2    -30358610  
II. ACE model without sex difference 142642.5 4.3 2 0.12 -30358610 Model I 
III. AE model without sex difference a 142642.6 0.1 1 0.70 -30358611 Model II 
Figure 1. Risks (OR and 95% CI) for TS/CTD among first, second and third degree relatives of TS/CTD probands in the Swedish National 
Patient Register (1969-2009) compared to matched population controls. 
 
 
 
Legend: First-degree relatives included full siblings, parents, and children. Second-degree relatives included maternal and paternal half 
siblings, grandparents and grandchildren, uncles/aunts, and nephews/nieces. Third-degree relatives consisted of first cousins. 
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